Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Home - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 722239 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Printer Friendly
PDF Brochure
Send to Friend
Enquire before Buying
| More
ElectronicAdd to Basket



Wyeth - SWOT Analysis
Datamonitor, June 2009, Pages: 30


  Description  
  Table of Contents  
    
    
    
   
 Enquire before Buying  
 Send to a Friend  

The Wyeth - SWOT Analysis company profile is the essential source for top-level company data and information. Wyeth - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Wyeth, which is set to be part of the world’s largest pharmaceutical company following the $68-billion merger with Pfizer, is a diversified prescription pharmaceuticals and healthcare products provider. The company is engaged in the discovery, development, manufacture, distribution and sale of human ethical pharmaceuticals, biotechnology products, nutrition products, vaccines, and consumer and animal healthcare products. The company sells its products in 145 countries worldwide. It is headquartered in Madison, New Jersey and employed 47,426 people as of December 2008. The company recorded revenues of $22,833.9 million during the financial year (FY) ended December 2008, an increase of 1.9% over FY2007. The increase was mainly due to higher sales of Enbrel, Prevnar, and Zosyn. The operating profit of the company was $6,374.6 million during FY2008, an increase of 4.9% over FY2007. The net profit was $4,417.8 million in FY2008, a decrease of 4.3% over FY2007.

Scope of the Report

- Provides all the crucial information on Wyeth required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Wyeth in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Wyeth
-Data is supplemented with details on Wyeth history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Wyeth

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available


Customers who bought this item also bought

Analysis of Wyeth

Company Analysis - Wyeth

Wyeth - Financial and Strategic Analysis Review

Wyeth: Company Analysis

Financial Analysis - Wyeth

Wyeth

Wyeth - SWOT Framework Analysis

Wyeth: Performance, Products, Pipeline and Potential

Wyeth: PharmaVitae Profile

Wyeth: Pharmavitae Profile 2005

WYETH - World'Vest Base Dossier

Sonoco Products Company - SWOT Analysis



Top of page


   All rights reserved. © Copyright 2009 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster


Research and Markets RSS Feeds